8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Mar 28, 2024 · 2y ago · Accession 0001453687-24-000048
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Cartesian Therapeutics, Inc.
- Ticker
- RNAC
- CIK
- 1453687
- Form type
- 8-K
- Filing date
- Mar 28, 2024
- Report date
- Mar 26, 2024
- Document
- rnac-20240326.htm
- Size
- 255 KB